Acadia Pharmaceuticals buy klostergang
Start price
06.02.17
/
50%
€33.78
Target price
11.10.18
€43.30
Performance (%)
-45.96%
End price
11.10.18
€18.26
Summary
This prediction ended on 11.10.18 with a price of €18.26. Massive losses of -45.96% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Acadia Pharmaceuticals | - | - | - | - |
iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
Comments by klostergang for this prediction
In the thread Acadia Pharmaceuticals diskutieren
Ist Acad im Übernahmemodus?
klostergang stimmt am 06.02.2017 der Buy-Einschätzung von marge mit dem Kursziel 58$ zu.Überschrift: Blockbuster-Potential zur Behandlung für Patienten mit Parkinson Psychose :
(Laufzeit überschritten)
Stopped prediction by klostergang for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
12.10.18
12.10.18
€56.30
04.11.21
04.11.21
10.97%
17.06.21
17.06.21